Back
31
Day Range
$33.98
$34.59
52-Week Range
$22.66
$55.00
Volume
403,560
50D / 200D Avg
$42.59
/
$35.79
Prev Close
$33.09
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 759.7 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | 0.2 | 3.8 |
| Net Margin % | 0.2 | 3.9 |
| Rev Growth 5Y % | 1.2 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$55.25
+61.0%
Low: $49.00
High: $60.00
Forward P/E
19.6
Forward EPS
$1.75
EPS Growth (est.)
+0.0%
Est. Revenue
1.2 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$2.53
$2.47 – $2.58
|
1.4 B | 1 |
| FY2027 |
$2.09
$1.82 – $2.49
|
1.3 B | 6 |
| FY2026 |
$1.75
$1.67 – $1.85
|
1.2 B | 6 |
Key Takeaways
Revenue grew 1.15% annually over 5 years — modest growth
Earnings declined -83.62% over the past year
ROE of 0.17% is below average
Debt/Equity of 0.17 — conservative balance sheet
Generating 86.89M in free cash flow
P/E of 759.70 — premium valuation
Growth
Revenue Growth (5Y)
1.15%
Revenue (1Y)6.53%
Earnings (1Y)-83.62%
FCF Growth (3Y)-21.11%
Quality
Return on Equity
0.17%
ROIC0.27%
Net Margin0.17%
Op. Margin0.44%
Safety
Debt / Equity
0.17
Current Ratio1.43
Interest Coverage0.84
Valuation
P/E Ratio
759.70
P/B Ratio1.27
EV/EBITDA303.63
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.53% | Revenue Growth (3Y) | 1.63% |
| Earnings Growth (1Y) | -83.62% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1.15% | Earnings Growth (5Y) | -59.71% |
| Profitability | |||
| Revenue (TTM) | 1.18B | Net Income (TTM) | 2.05M |
| ROE | 0.17% | ROA | 0.10% |
| Gross Margin | 42.49% | Operating Margin | 0.44% |
| Net Margin | 0.17% | Free Cash Flow (TTM) | 86.89M |
| ROIC | 0.27% | FCF Growth (3Y) | -21.11% |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | 1.43 |
| Interest Coverage | 0.84 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 759.70 | P/B Ratio | 1.27 |
| P/S Ratio | 1.32 | PEG Ratio | -12.16 |
| EV/EBITDA | 303.63 | Dividend Yield | 0.00% |
| Market Cap | 1.56B | Enterprise Value | 1.57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.18B | 1.11B | 1.15B | 1.30B | 1.13B |
| Net Income | 2.05M | 12.53M | -20.37M | 5.65M | 77.85M |
| EPS (Diluted) | 0.04 | 0.27 | -0.45 | 0.12 | 1.62 |
| Gross Profit | 503.44M | 471.00M | 499.93M | 588.99M | 554.65M |
| Operating Income | 5.16M | 337,000.0 | -19.33M | -2.32M | 89.51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.97B | 2.12B | 2.23B | 2.21B | 2.14B |
| Total Liabilities | 742.91M | 877.65M | 1.04B | 1.08B | 995.81M |
| Shareholders' Equity | 1.23B | 1.24B | 1.19B | 1.13B | 1.15B |
| Total Debt | 204.35M | 382.55M | 614.09M | 616.74M | 541.01M |
| Cash & Equivalents | 196.52M | 369.20M | 467.97M | 330.36M | 349.05M |
| Current Assets | 680.07M | 815.49M | 927.57M | 881.81M | 780.70M |
| Current Liabilities | 476.61M | 595.68M | 367.79M | 428.45M | 876.16M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#800 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026